Mental Disorders Clinical Trial
— PROTECTOfficial title:
A Randomized Efficacy Trial of a Cognitive-Behavioral Intervention to Prevent Internet Use Disorder Onset in Adolescents: the PROTECT Study
Verified date | September 2017 |
Source | Pädagogische Hochschule Heidelberg |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background. The reduction of prevalence rates of Internet Use Disorder (IUD) and its
effective treatment are at high priority in both public health and educational policies.
School-based preventive interventions facilitate a low-threshold approach for individuals
with IUD, who are typically characterized by high therapy avoidance. Moreover, indicated
approaches which target adolescents at high-risk show larger effects than universal
prevention approaches. Simultaneously, they reduce unnecessary burden for the majority of
high-school students that is not at-risk. The PROTECT intervention for indicated prevention
of IUD in school settings was developed based on these preventive strategies.
Methods. Three-hundred and forty adolescents, aged 12-18 years, from 40 secondary schools in
Germany, screened for high-risk of IUD onset, will be randomly assigned to a) PROTECT
intervention group or b) assessment only control group. The tested intervention consists of a
cognitive-behavioral 4-session brief-protocol. Follow-up assessments are at 1, 4 and 12
months after admission. Primary outcome is the 12-months incidence rate of IUD. Secondary
outcomes are the reduction of IUD and comorbid symptoms and the promotion of problem solving,
cognitive restructuring and emotion regulation skills.
Discussion. The indicated preventive intervention PROTECT follows the APA-guidelines for
psychological prevention. It is theory- and evidence-based (guideline 1) and addresses both
risk-reduction and strength-promotion (guideline 3), it considers current research and
epidemiology (guideline 4) and ethical standards (guideline 5) such as professional secrecy
and is designed as a systemic intervention (guideline 8) at the school-level. It is expected
that the intervention decreases risk of IUD onset (incidence rate).
Status | Active, not recruiting |
Enrollment | 480 |
Est. completion date | May 2018 |
Est. primary completion date | April 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Adolescents aged 12 to 18 years - Written informed consent - High-risk for IUD (Screening: CIUS >= 20) Exclusion Criteria: - Current IUD diagnosis or treatment - Comorbid depression - Comorbid anxiety disorder (social phobia or performance anxiety) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Pädagogische Hochschule Heidelberg | Dietmar Hopp Stiftung |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Internet Use Disorder 12-months incidence rate (Clinical Interview for DSM-5 Diagnosis) | We use a clinical interview (blinded rater) based on the criteria of Internet Gaming Disorder according to the DSM-5 at the 12-month follow-up. We adapted the criteria to assess IUD (including gaming and non-gaming subtypes). | 12 months | |
Primary | Internet Use Disorder 12-months incidence rate (Self-Report) | We use the German "Computerspielabhängigkeitsskala" (CSAS; Rehbein, Baier, Kleimann & Mößle, 2015), a self-report questionnaire which assesses DSM-5 criteria for Internet Gaming Disorder proposed in DSM-5 section 3 (American Psychiatric Association, 2013): (1) preoccupation, (2) withdrawal, (3) tolerance, (4) unsuccessful attempts to control, (5) loss of interest in other activities, (6) continued excessive use despite problems, (7) deception (8) maladaptive coping, (9) loss of relationship, job, or educational or career opportunities. We adapted the criteria to assess IUD (including gaming and non-gaming subtypes). | 12 months | |
Primary | Changes in Internet Use Disorder prevalence | To measure the IUD prevalence rate over time (at baseline, 1 month, 4-months, 12-months), we use the adapted version of the CSAS questionnaire. | baseline, 1 month, 4-months, 12-months | |
Secondary | Emotion Regulation | For the measurement of emotion regulation the German Questionnaire for Assessment of Emotion Regulation in Children and Adolescents (Fragebogen zur Erhebung der Emotionsregulation bei Kindern und Jugendlichen, FEEL-KJ; Grob & Smolenski, 2011) is used. The questionnaire includes a measure of functional and dysfunctional emotion regulation strategies for the negative emotions fear, sadness and anger. | baseline, 1 month, 4-months, 12-months | |
Secondary | Depressive Symptoms | Depressive symptoms are assessed using the German Depression Inventory for Children and Adolescents (DIKJ; Stiensmeier-Pelster, Braune-Krickau, Schürmann & Duda, 2014; Stiensmeier-Pelster, Schürmann & Duda, 1989). The instrument allows for the detection and estimation of severity of depressive disorders according to the DSM-5 criteria (American Psychiatric Association, 2013). | baseline, 1 month, 4-months, 12-months | |
Secondary | Comorbid emotional, oppositional, antisocial and attention deficit/ hyperactivity disorders | Comorbid Psychopathology is assessed using the Strength and Difficulties Questionnaire (SDQ; Goodman, Meltzer & Bailey, 2003). It includes the 5 scales (1) emotional problems, (2) behaviour problems, (3) hyperactivity/ attention deficits, (4) interpersonal problems with peers and (5) prosocial behaviour and can be used for epidemiological research and as an indicator for emotional, oppositional, antisocial and attention deficit/ hyperactivity disorder. |
baseline, 1 month, 4-months, 12-months | |
Secondary | Anxiety Disorders: Social Anxiety | We assess social anxiety using the German version of the Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998; Stangier, Heidenreich, Berardi, Golbs & Hoyer, 1999) is used. This questionnaire assesses anxiety in social interactions and al-lows for detection and the estimation of severity of social anxiety disorders. 2) Performance and school anxiety are assessed with the 7th scale of the German adaption of the Fear Survey Schedule for Children - Revised (Phobiefragebogen für Kinder und Jugendliche, PHOKI Döpfner, Schnabel, Goletz & Ollendick, 2006; Muris & Ollendick, 2002). |
baseline, 1 month, 4-months, 12-months | |
Secondary | Anxiety Disorders: Performance and School Anxiety | We assess performance and school anxiety with the 7th scale of the German adaption of the Fear Survey Schedule for Children - Revised (Phobiefragebogen für Kinder und Jugendliche, PHOKI Döpfner, Schnabel, Goletz & Ollendick, 2006; Muris & Ollendick, 2002). | baseline, 1 month, 4-months, 12-months | |
Secondary | Procrastination | Procrastination is assessed with the German Questionnaire for Procrastination (APROF; Höcker, Engberding & Rist, 2013). | baseline, 1 month, 4-months, 12-months | |
Secondary | Social Behavior and Learning Behavior | For ratings of social competent behaviour and academic motivation, we use the German Student Assessment List for Social and Learning Behaviour (SSL; Petermann & Petermann, 2014; Petermann, Petermann & Lohbeck, 2014). | baseline, 1 month, 4-months, 12-months | |
Secondary | Self-Efficacy | Self- efficacy is rated on the German Self-Efficacy Scale (Allgemeine Selbstwirksamkeitserwartung, SWE; Schwarzer & Jerusalem, 1999). | baseline, 1 month, 4-months, 12-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
Recruiting |
NCT06012149 -
Braining: Implementation of Physical Exercise for Patients in Specialist Psychiatry
|
N/A | |
Recruiting |
NCT03222375 -
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
Active, not recruiting |
NCT02836080 -
Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)
|
N/A | |
Completed |
NCT02710344 -
Using Telehealth to Improve Psychiatric Symptom Management
|
N/A | |
Enrolling by invitation |
NCT02487888 -
A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Active, not recruiting |
NCT02761733 -
The Effectiveness of a Decision-Support Tool for Adult Consumers With Mental Health Needs and Their Care Managers
|
N/A | |
Completed |
NCT01947283 -
Effectiveness of DECIDE in Patient-Provider Communication, Therapeutic Alliance & Care Continuation
|
N/A | |
Completed |
NCT01633138 -
Performance-based Reinforcement to Enhance Cognitive Remediation Therapy
|
N/A | |
Completed |
NCT01690013 -
Life Quality and Health in Patients With Klinefelter Syndrome
|
N/A | |
Completed |
NCT01656707 -
Adaptive Treatment for Adolescent Cannabis Use Disorders
|
N/A | |
Completed |
NCT01415323 -
Agitation in the Acute Psychiatric Department
|
||
Completed |
NCT01701765 -
Outcomes and Discharge of Long-stay Psychiatric Patients
|
N/A | |
Completed |
NCT00375167 -
Efficacy of the Recovery Workbook as a Psychoeducational Tool for Facilitating Recovery
|
N/A | |
Terminated |
NCT00757497 -
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
|
Phase 1 | |
Terminated |
NCT03527550 -
Cognitive Control Training for Urgency in a Naturalistic Clinical Setting
|
N/A | |
Withdrawn |
NCT03518996 -
Non-Invasive Brain Stimulation and Delirium
|
N/A | |
Completed |
NCT02707848 -
Epidemiological Study for Psychiatric Disorder Among Children and Adolescents
|